# Aeluma, Inc.: financial statements, quarterly

ALMU · Nasdaq · CIK 1828805 · [Technology](/sectors/technology.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/almu.md) · [Financials](/companies/almu/financials.md) · [Filings](/companies/almu/filings.md) · [Insiders](/companies/almu/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/almu/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [32.4](/filings/0001213900-24-095832.md) | [263](/filings/0001213900-25-012068.md) | [344](/filings/0001213900-25-041444.md) | [280 d](/filings/0001213900-25-086227.md) | [481](/filings/0001213900-25-109328.md) | [1,612](/filings/0001213900-26-014999.md) | [1,255](/filings/0001213900-26-055956.md) | [1,317 d](/filings/0001213900-26-100584.md) | [1,385](/filings/0001213900-25-109328.md) | [1,272](/filings/0001213900-26-014999.md) | [1,222](/filings/0001213900-26-055956.md) | [582 d](/filings/0001213900-26-100584.md) |
| Cost of revenue | $k | [15.1](/filings/0001213900-24-095832.md) | [137](/filings/0001213900-25-012068.md) | [234](/filings/0001213900-25-041444.md) | [234 d](/filings/0001213900-25-086227.md) | [315](/filings/0001213900-25-109328.md) | [584](/filings/0001213900-26-014999.md) | [311](/filings/0001213900-26-055956.md) | [779 d](/filings/0001213900-26-100584.md) | [701](/filings/0001213900-25-109328.md) | [919](/filings/0001213900-26-014999.md) | [836](/filings/0001213900-26-055956.md) | [433 d](/filings/0001213900-26-100584.md) |
| Research and development | $k | [835](/filings/0001213900-24-095832.md) | [651](/filings/0001213900-25-012068.md) | [620](/filings/0001213900-25-041444.md) | [401 d](/filings/0001213900-25-086227.md) | [401](/filings/0001213900-25-109328.md) | [268](/filings/0001213900-26-014999.md) | [471](/filings/0001213900-26-055956.md) | [165 d](/filings/0001213900-26-100584.md) | [606](/filings/0001213900-25-109328.md) | [906](/filings/0001213900-26-014999.md) | [882](/filings/0001213900-26-055956.md) | [2,274 d](/filings/0001213900-26-100584.md) |
| Operating income | $k | [(1,483)](/filings/0001213900-24-095832.md) | [(1,129)](/filings/0001213900-25-012068.md) | [(963)](/filings/0001213900-25-041444.md) | [(989) d](/filings/0001213900-25-086227.md) | [(731)](/filings/0001213900-25-109328.md) | [389](/filings/0001213900-26-014999.md) | [(2,087)](/filings/0001213900-26-055956.md) | [2,380 d](/filings/0001213900-26-100584.md) | [(1,608)](/filings/0001213900-25-109328.md) | [(2,081)](/filings/0001213900-26-014999.md) | [(3,347)](/filings/0001213900-26-055956.md) | [(493) d](/filings/0001213900-26-100584.md) |
| Interest expense | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | [(1,482)](/filings/0001213900-24-095832.md) | [(1,129)](/filings/0001213900-25-012068.md) | [(963)](/filings/0001213900-25-041444.md) | [(989) d](/filings/0001213900-25-086227.md) | [(730)](/filings/0001213900-25-109328.md) | [(2,895)](/filings/0001213900-26-014999.md) | [1,461](/filings/0001213900-26-055956.md) | [(858) d](/filings/0001213900-26-100584.md) | [(1,493)](/filings/0001213900-25-109328.md) | [(1,853)](/filings/0001213900-26-014999.md) | [(1,800)](/filings/0001213900-26-055956.md) | [(4,013) d](/filings/0001213900-26-100584.md) |
| Diluted EPS | $ per share | [(0.12)](/filings/0001213900-24-095832.md) | [(0.09)](/filings/0001213900-25-012068.md) | [(0.08)](/filings/0001213900-25-041444.md) | not reported | [(0.06)](/filings/0001213900-25-109328.md) | [(0.24)](/filings/0001213900-26-014999.md) | [0.11](/filings/0001213900-26-055956.md) | not reported | [(0.09)](/filings/0001213900-25-109328.md) | [(0.11)](/filings/0001213900-26-014999.md) | [(0.10)](/filings/0001213900-26-055956.md) | not reported |
| Basic EPS | $ per share | [(0.12)](/filings/0001213900-24-095832.md) | [(0.09)](/filings/0001213900-25-012068.md) | [(0.08)](/filings/0001213900-25-041444.md) | not reported | [(0.06)](/filings/0001213900-25-109328.md) | [(0.24)](/filings/0001213900-26-014999.md) | [0.12](/filings/0001213900-26-055956.md) | not reported | [(0.09)](/filings/0001213900-25-109328.md) | [(0.11)](/filings/0001213900-26-014999.md) | [(0.10)](/filings/0001213900-26-055956.md) | not reported |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | period not labelled (2024-08-27) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [2.4](/filings/0001213900-24-012610.md) | [1.9](/filings/0001213900-24-041529.md) | [1.3](/filings/0001213900-25-086227.md) | not reported | [3.5](/filings/0001213900-24-095832.md) | [3.1](/filings/0001213900-25-012068.md) | [3.9](/filings/0001213900-25-041444.md) | [3.6](/filings/0001213900-26-100584.md) | [25.9](/filings/0001213900-25-109328.md) | [38.6](/filings/0001213900-26-014999.md) | [37.8](/filings/0001213900-26-055956.md) | [56.0](/filings/0001213900-26-100584.md) |
| Current assets | $m | [2.8](/filings/0001213900-24-012610.md) | [2.1](/filings/0001213900-24-041529.md) | [1.4](/filings/0001213900-25-086227.md) | not reported | [4.0](/filings/0001213900-24-095832.md) | [4.5](/filings/0001213900-25-012068.md) | [17.2](/filings/0001213900-25-041444.md) | [17.3](/filings/0001213900-26-100584.md) | [40.2](/filings/0001213900-25-109328.md) | [40.3](/filings/0001213900-26-014999.md) | [40.2](/filings/0001213900-26-055956.md) | [57.3](/filings/0001213900-26-100584.md) |
| Total assets | $m | [5.3](/filings/0001213900-24-012610.md) | [4.7](/filings/0001213900-24-041529.md) | [3.8](/filings/0001213900-25-086227.md) | not reported | [6.3](/filings/0001213900-24-095832.md) | [6.8](/filings/0001213900-25-012068.md) | [19.4](/filings/0001213900-25-041444.md) | [19.4](/filings/0001213900-26-100584.md) | [42.7](/filings/0001213900-25-109328.md) | [42.6](/filings/0001213900-26-014999.md) | [42.5](/filings/0001213900-26-055956.md) | [60.7](/filings/0001213900-26-100584.md) |
| Current liabilities | $m | [0.5](/filings/0001213900-24-012610.md) | [0.6](/filings/0001213900-24-041529.md) | [0.6](/filings/0001213900-25-086227.md) | not reported | [2.6](/filings/0001213900-24-095832.md) | [0.5](/filings/0001213900-25-012068.md) | [0.5](/filings/0001213900-25-041444.md) | [0.7](/filings/0001213900-26-100584.md) | [0.8](/filings/0001213900-25-109328.md) | [0.8](/filings/0001213900-26-014999.md) | [1.5](/filings/0001213900-26-055956.md) | [1.9](/filings/0001213900-26-100584.md) |
| Total liabilities | $m | [1.5](/filings/0001213900-24-012610.md) | [1.6](/filings/0001213900-24-041529.md) | [1.6](/filings/0001213900-25-086227.md) | not reported | [4.6](/filings/0001213900-24-095832.md) | [7.8](/filings/0001213900-25-012068.md) | [1.4](/filings/0001213900-25-041444.md) | [1.5](/filings/0001213900-26-100584.md) | [1.8](/filings/0001213900-25-109328.md) | [1.8](/filings/0001213900-26-014999.md) | [2.4](/filings/0001213900-26-055956.md) | [3.7](/filings/0001213900-26-100584.md) |
| Current portion of debt | $m | not reported | not reported | not reported | [3.1](/filings/0001213900-25-109328.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [3.9](/filings/0001213900-25-041444.md) | [3.1](/filings/0001213900-25-041444.md) | [2.3](/filings/0001213900-26-100584.md) | not reported | [1.7](/filings/0001213900-26-014999.md) | [(1.0)](/filings/0001213900-26-055956.md) | [18.0](/filings/0001213900-26-055956.md) | [17.9](/filings/0001213900-26-100584.md) | [40.9](/filings/0001213900-26-014999.md) | [40.8](/filings/0001213900-26-055956.md) | [40.1](/filings/0001213900-26-055956.md) | [56.9](/filings/0001213900-26-100584.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(1,303)](/filings/0001213900-24-095832.md) | [(1,177) d](/filings/0001213900-25-012068.md) | [(396) d](/filings/0001213900-25-041444.md) | [(579) d](/filings/0001213900-25-086227.md) | [(931)](/filings/0001213900-25-109328.md) | [(401) d](/filings/0001213900-26-014999.md) | [249 d](/filings/0001213900-26-055956.md) | [(65.0) d](/filings/0001213900-26-100584.md) | [(815)](/filings/0001213900-25-109328.md) | [(251) d](/filings/0001213900-26-014999.md) | [(577) d](/filings/0001213900-26-055956.md) | [(1,623) d](/filings/0001213900-26-100584.md) |
| Capital expenditure | $k | [6.6](/filings/0001213900-24-095832.md) | [158 d](/filings/0001213900-25-012068.md) | [153 d](/filings/0001213900-25-041444.md) | [5.1 d](/filings/0001213900-25-086227.md) | [2.0](/filings/0001213900-25-109328.md) | [39.0 d](/filings/0001213900-26-014999.md) | [44.0 d](/filings/0001213900-26-055956.md) | [76.0 d](/filings/0001213900-26-100584.md) | [210](/filings/0001213900-25-109328.md) | [31.0 d](/filings/0001213900-26-014999.md) | [198 d](/filings/0001213900-26-055956.md) | [207 d](/filings/0001213900-26-100584.md) |
| Share repurchases | $k | [4.0](/filings/0001213900-24-095832.md) | [0.0 d](/filings/0001213900-25-012068.md) | [0.0 d](/filings/0001213900-25-041444.md) | [(0.0) d](/filings/0001213900-25-086227.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | billions of shares | [0.0](/filings/0001213900-23-085258.md) | [0.0](/filings/0001213900-24-012610.md) | [0.0](/filings/0001213900-24-041529.md) | [0.0](/filings/0001213900-24-095832.md) | [0.0](/filings/0001213900-25-012068.md) | [0.0](/filings/0001213900-25-041444.md) | [0.0](/filings/0001213900-25-109328.md) | [0.0](/filings/0001213900-26-014999.md) | [13.2](/filings/0001213900-26-055956.md) | [0.0](/filings/0001213900-25-109328.md) | [0.0](/filings/0001213900-26-014999.md) | [18.1](/filings/0001213900-26-055956.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 19,265,671 at 2026-09-11, from the cover of the [10-K filed 2026-09-16](/filings/0001213900-26-100584.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.